Skip to main content
SpringerLink
Log in

Development of a Recombinant FIMCH Vaccine for Urinary Tract Infections

  • Chapter
Bladder Disease, Part A

Abstract

Urinary tract infections (UTI) comprise an important group of clinical syndromes that are classified as either uncomplicated or complicated, according to their presentation or response to therapy and the presence of underlying risk factors. UTI can be further divided into relatively distinct clinical entities that include acute uncomplicated UTI in women, acute uncomplicated pyelonephritis, complicated UTI and UTI in men, asymptomatic bacteruria, and recurrent UTI. This chapter will focus primarily on the syndrome of uncomplicated UTI in women, which makes up by far the largest single category of UTI seen by physicians in practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham SN, et al: Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors. Infect Immun, 48:625, 1985.

    PubMed  CAS  Google Scholar 

  2. Arav-Boger, Leibovici RL, Danon YL: Urinary tract infections with low and high colony counts in young women: Spontaneous remission and single-dose vs. multiple-day treatment. Arch Int Med, 154:300, 1994.

    Article  CAS  Google Scholar 

  3. Barnett BJ, Stephens DS: Urinary tract infections: an overview. Am J Med Sci, 314:245, 1997.

    Article  PubMed  CAS  Google Scholar 

  4. Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, Hultgren SJ, et al: X-ray Structure of the FimC-FimH Chaperone-Adhesin Complex from Uropathogenic Escherichia coli. Science, 285:1061, 1999.

    Article  PubMed  CAS  Google Scholar 

  5. Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science, 284(5418):1318, 1999.

    Article  PubMed  CAS  Google Scholar 

  6. De Donato S, Granoff D, Minutello M, Lecchi G, Faccini M, Agnello M, et al: Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine, 17:3094, 1999.

    Article  PubMed  Google Scholar 

  7. Delzell JE, Lefevre ML: Urinary tract infections during pregnancy. Am Fam Physician, 61:713, 2000.

    PubMed  Google Scholar 

  8. Dodson K, Jacob-Dubuisson F, Striker RT, Hultgren SJ: Outer-membrane PapC molecular usher discriminately recognizes periplasmic chaperone-pilus subunit complexes. Proc Natl Acad Sci USA, 90:3670, 1996.

    Article  Google Scholar 

  9. Elo J, Tallgren LG, Vaisanen V, Korhonen TK, Svenson SB, Makela PH: Association of P and other fimbriae with clinical pyelonephritis in children. Scand J Urol Nephrol, 19:281, 1985.

    Article  PubMed  CAS  Google Scholar 

  10. Gupta K, Scholes D, Stamm WE: Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA, 281:736, 1999.

    Article  PubMed  CAS  Google Scholar 

  11. Hanson MS, Brinton CC: Identification and characterization of E. coli type-1 pilus tip adhesion protein. Nature, 332:265, 1988.

    Article  PubMed  CAS  Google Scholar 

  12. Hooton TM, Scholes D, Hughes J, Winter C, Roberts P, Stapleton A, et al: A prospective study of risk factors for symptomatic urinary tract infection in young women. New Engl J Med, 335:468, 1996.

    Article  PubMed  CAS  Google Scholar 

  13. Hultgren SJ, Abraham S, Caparon M, Falk P, St Geme III JW, Normark S: Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell, 73:887, 1993.

    Article  PubMed  CAS  Google Scholar 

  14. Hultgren SJ, Normark S, Abraham SN: Chaperone-assisted assembly and molecular architecture of adhesive pili. Annu Rev Microbiol, 45:383, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Hultgren SJ, Schwan WR, Schaeffer AY, Duncan JL: Regulation of Production of Type 1 Pili Among Urinary Tract Isolates of Escherichia coli. Infect Immun, 54:613, 1986.

    PubMed  CAS  Google Scholar 

  16. Hung DL, Hultgren SJ: Pilus biogenesis via the chaperone/usher pathway: an integration of structure and function. J Struct Biol, 124(2–3):201, 1998.

    Article  PubMed  CAS  Google Scholar 

  17. Hung DL, Knight SD, Woods RM, Pinkner JS, Hultgren SJ: Molecular basis of two subfanilies of immunoglobulin-like chaperones. EMBO J, 15:379, 1996.

    Google Scholar 

  18. Jacob-Dubuisson F, Kuehn M, Hultgren SJ: A novel secretion apparatus for the assembly of adhesive bacterial pili. Trends in Microbiol, 1:50, 1993.

    Article  CAS  Google Scholar 

  19. Johnson JR, Stamm WE: Diagnosis and treatment of urinary tract infections. Infect Dis Clin North Am, 1:773, 1987.

    PubMed  CAS  Google Scholar 

  20. Johnson JR, Stamm WE: Urinary tract infections in women: diagnosis and treatment. Ann Int Med, 111:906, 1989.

    Article  PubMed  CAS  Google Scholar 

  21. Jones CH, Pinkner JS, Nicholes AV, Slonim LN, Abraham SN, Hultgren SJ, et al: FimC is a periplasmic PapD-like chaperone that directs assembly of type 1 pili in bacteria. Proc Natl Acad Sci USA, 90:8397, 1993.

    Article  PubMed  CAS  Google Scholar 

  22. Jones CH, Pinkner JS, Roth R, Heuser J, Nicholes AV, Abraham SN, et al: FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriacae. Proc Natl Acad Sci, 92:2081, 1995.

    Article  PubMed  CAS  Google Scholar 

  23. Kallenius G, Svenson SB, Hultberg H, Mollby R, Helin I, Cedergen B, et al: Occurrence of P-fimbriated Escherichia coli in urinary tract infection. Lancet, II: 1369, 1981.

    Article  Google Scholar 

  24. Kass EH: Bacteruria and the diagnosis of infection of the urinary tract, with observations on the use of methionine as a urinary antiseptic. Arch Intern Med, 100:709, 1957.

    Article  CAS  Google Scholar 

  25. Kass EH, Finland M: Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians, 69:56, 1956.

    PubMed  CAS  Google Scholar 

  26. Kisielius PV, Schwan WR, Amundsen SK, Duncan JL, Schaeffer AJ, et al: In vivo Expression and Variation of Escherichia coli Type 1 and P Pili in the Urine of Adults With Acute Urinary Tract Infections. Infect Immun, 57:1656, 1989.

    PubMed  CAS  Google Scholar 

  27. Kuehn MJ, Heuser J, Normark S, Hultgren SJ: P Pil in uropathogenic E. coli are composite fibres with distinct fibrillar adhesive tips. Nature, 356:252, 1992.

    Article  PubMed  CAS  Google Scholar 

  28. Kuehn MJ, Normark S, Hultgren SJ: Immunoglobulin-like PapD chaperone caps and uncaps interactive surfaces of nascently translocated pilus subunits. Proc Natl Acad Sci USA, 88(23):10586, 1991.

    Article  PubMed  CAS  Google Scholar 

  29. Kunin CM: Urinary tract infections in females. Clin Infect Dis, 18:1, 1994.

    Article  PubMed  CAS  Google Scholar 

  30. Langermann S, Mollby R, Burlein JE, Palaszynski SR, Auguste CG, DeFusco A, et al: Vaccination with FimH Adhesin Protects Cynomolgus Monkeys from Colonization and Infection by Uropathogenic Escherichia coli. J Infect Dis, 181:774, 2000.

    Article  PubMed  CAS  Google Scholar 

  31. Langermann S, Palazynski S, Barnhart M, Auguste G, Pinkner J, Burlein J, et al: Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science, 276:607, 1997.

    Article  PubMed  CAS  Google Scholar 

  32. Li H, Walker DH: Characterization of Rickettsial Attachment to Host Cells by Flow Cytometry. Infect Immu., 60:2030, 1992.

    CAS  Google Scholar 

  33. Minutello M, Senatore F, Cecchinelli G, Bianchi M, Andreani T, Podda A, et al: Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons. Vaccine, 17(2):99, 1999.

    Article  PubMed  CAS  Google Scholar 

  34. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, et al: Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science, 282:1494, 1998.

    Article  PubMed  CAS  Google Scholar 

  35. Ofek I, Mosek A, Sharon N, et al: Mannose-specific adherence of Escherichia coli freshly excreted in the urine of patients with acute urinary tract infections and of isolates subcultured from the infected urine. Infect Imm, 34:708, 1981.

    CAS  Google Scholar 

  36. O’Hanley P, Lark D, Falkow S, Schoolnik G: Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis. J Clin Invest, 75:347, 1985.

    Article  PubMed  Google Scholar 

  37. Roberts JA: Contribution of experimental pathology to the understanding of human pyelonephritis. J Urol, 148:1721, 1992.

    PubMed  CAS  Google Scholar 

  38. Roberts JA: Vesicoureteral reflux and pyelonephritis in the monkey: a review. Urol., 148:1721, 1992.

    CAS  Google Scholar 

  39. Roberts JA, Marklund BI, Ilver D, Haslam D, Kaack MB, Baskin G, et al: The Gal(alpha l-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA, 91:11889, 1994.

    Article  PubMed  CAS  Google Scholar 

  40. Sauer FG, Fütterer K, Pinkner JS, Dodson KW, Hultgren SJ, Waksman G: Structural Basis of Chaperone Function and Pilus Biogenesis. Science, 285:1058, 1999.

    Article  PubMed  CAS  Google Scholar 

  41. Saulino ET, Thanassi DG, Pinkner J, Hultgren SJ: Ramifications of kinetic partitioning on usher-mediated pilus biogenesis. EMBO J, 17(8):2177, 1998.

    Article  PubMed  CAS  Google Scholar 

  42. Stamey TA, Sexton CC: The role of vaginal colonization with Enterobacteriaceae in recurrent urinary tract infections. J Urol, 113:214, 1975.

    PubMed  CAS  Google Scholar 

  43. Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK: Diagnosis of coliform infection in acutely dysuric women. N Eng J Med, 307:463, 1982.

    Article  CAS  Google Scholar 

  44. Thanassi DG, Saulino ET, Hultgren SJ: The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Curr Opin Microbiol, 1:223, 1998.

    Article  PubMed  CAS  Google Scholar 

  45. Thanassi DG, Saulino ET, Lombardo MJ, Roth R, Heuser J, Hultgren SJ: The PapC usher forms an oligomeric channel: implications for pilus biogenesis across the outer membrane. Proc Natl Acad Sci USA, 95(6):3146, 1998.

    Article  PubMed  CAS  Google Scholar 

  46. Vaisanen V, Tallgren L, Makela P, et al: Mannose Resistant Hemagglutination and P Antigen Recognition Are Characteristics of Escherichia coli Causing Primary Pyelonephritis. Lancet, 2:1366, 1981.

    Article  PubMed  CAS  Google Scholar 

  47. Wu X-R, Sun T-T, Medina JJ: In vitro binding of type 1-fimbriated Escherichia coli to uroplakins la and lb: relation to urinary tract infections. Proc Natl Acad Sci USA, 93:9630, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MedImmune, Inc., Gaithersburg, MD, USA

    Solomon Langermann & W. Ripley Ballou

Authors
  1. Solomon Langermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Ripley Ballou
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Anthony Atala

  2. Ridgefield, Connecticut, USA

    Debra Slade

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Langermann, S., Ballou, W.R. (2003). Development of a Recombinant FIMCH Vaccine for Urinary Tract Infections. In: Atala, A., Slade, D. (eds) Bladder Disease, Part A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8889-8_41

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8889-8_41

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4707-1

  • Online ISBN: 978-1-4419-8889-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation